Correlation Between Armada Hflr and Shanghai Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Armada Hflr and Shanghai Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Armada Hflr and Shanghai Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Armada Hflr Pr and Shanghai Pharmaceuticals Holding, you can compare the effects of market volatilities on Armada Hflr and Shanghai Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Armada Hflr with a short position of Shanghai Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Armada Hflr and Shanghai Pharmaceuticals.

Diversification Opportunities for Armada Hflr and Shanghai Pharmaceuticals

-0.67
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Armada and Shanghai is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding Armada Hflr Pr and Shanghai Pharmaceuticals Holdi in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Shanghai Pharmaceuticals and Armada Hflr is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Armada Hflr Pr are associated (or correlated) with Shanghai Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Shanghai Pharmaceuticals has no effect on the direction of Armada Hflr i.e., Armada Hflr and Shanghai Pharmaceuticals go up and down completely randomly.

Pair Corralation between Armada Hflr and Shanghai Pharmaceuticals

Considering the 90-day investment horizon Armada Hflr Pr is expected to under-perform the Shanghai Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Armada Hflr Pr is 1.35 times less risky than Shanghai Pharmaceuticals. The stock trades about -0.29 of its potential returns per unit of risk. The Shanghai Pharmaceuticals Holding is currently generating about 0.2 of returns per unit of risk over similar time horizon. If you would invest  147.00  in Shanghai Pharmaceuticals Holding on September 23, 2024 and sell it today you would earn a total of  11.00  from holding Shanghai Pharmaceuticals Holding or generate 7.48% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy95.45%
ValuesDaily Returns

Armada Hflr Pr  vs.  Shanghai Pharmaceuticals Holdi

 Performance 
       Timeline  
Armada Hflr Pr 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Armada Hflr Pr has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's technical indicators remain fairly strong which may send shares a bit higher in January 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.
Shanghai Pharmaceuticals 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Shanghai Pharmaceuticals Holding are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Shanghai Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.

Armada Hflr and Shanghai Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Armada Hflr and Shanghai Pharmaceuticals

The main advantage of trading using opposite Armada Hflr and Shanghai Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Armada Hflr position performs unexpectedly, Shanghai Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Shanghai Pharmaceuticals will offset losses from the drop in Shanghai Pharmaceuticals' long position.
The idea behind Armada Hflr Pr and Shanghai Pharmaceuticals Holding pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Complementary Tools

Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope